• Patient
  • Klinische Anwender
  • Forschungs Anwender
  • Über uns
Vivosight (Deutsch)
  • VivoSight-Scanner
    • Funktion
    • Häufig gestellte fragen
  • Untersuchungsablauf
  • Hautkrebs
    • Daten und Fakten
  • Kontakt
    • Scanner in Ihrer Nähe
  • Search
▼International (DE)
International (EN)
United States

Michelson Diagnostics closes £2.5 million First Tranche of £4.0 million

9th February 2015/in Firma, Pressemitteilungen /by rupert
Read more →

Andy Hill Appointed Chief Executive Officer

2nd February 2015/in Firma, Pressemitteilungen /by rupert
Read more →

German TV Talk Show highlights OCT technology!

17th January 2015/in In den Medien, VivoSight /by rupert
Read more →

OCT Workshops – Dates Announced!

1st December 2014/in Pressemitteilungen, VivoSight /by rupert
Read more →

VivoSight

9th October 2014/in Pressemitteilungen, VivoSight /by
Read more →

Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis

8th October 2014/in Pressemitteilungen, VivoSight /by rupert
Read more →

VivoSight at EADV

1st October 2014/in Pressemitteilungen, VivoSight /by rupert
Read more →

VivoSight OCT scanner, images and data to be presented at ADO Hautkrebs 2014, Frankfurt Am Main, 11-13th September 2014

8th September 2014/in Pressemitteilungen, VivoSight /by rupert
Read more →

Michelson to exhibit at EADV Conference 8-12 October

1st September 2014/in Pressemitteilungen, VivoSight /by rupert
Read more →

Michelson Diagnostics to present at Fortbildungswoche, Munich

18th July 2014/in Pressemitteilungen, VivoSight /by rupert
Read more →
Page 2 of 512345

Recent Posts

  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • (no title)

Categories

  • Appointments
  • Autoimmun-Erkrankungen
  • Clinical Evidence
  • Corporate
  • Corporate
  • Entzündliche Erkrankungen
  • Events
  • Financing
  • Klinische Anwendung
  • Media Coverage
  • Nagelpilz und Erkrankungen des Nagelapparates
  • News
  • Nicht-melanozytäre Haut-Tumore und aktinische Keratose
  • OCT
  • Präoperative Tumorrand-Bestimmung
  • Press Release
  • Uncategorised
  • VivoSight
  • VivoSight
  • Weitere Anwendungen in der Dermatologie und Übersichtsartikel
  • Wundheilung, Narben und Verbrennungen

MICHELSON DIAGNOSTICS

Über uns
Karriere
Das Team
Aktuelles

 

 

KONTAKT

Agentur:
DermoScan GmbH
Ohmstraße 1, D-93055 Regensburg

T: +49 (0) 941 599 525 0
F: +49 (0) 32 211089 90002

E: info.de@vivosight.com

LEGAL

Impressum
Datenschutzerklärung
Cookie policy

Scroll to top